| TIVA Group | TIHA Group | P Value |
---|---|---|---|
 | (n = 56) | (n = 60) |  |
Age (yr) | 64 [57, 71] | 66 [56, 73] | 0.543 |
Sex (M/F) | 33/23 | 38/22 | 0.672 |
Body mass index (kg/m2) | 23.1 [20.8, 25.5] | 23.6 [21.8, 25.6] | 0.226 |
ASA grade (I/II/III) | 0/28/28 | 0/29/31 | 0.483 |
Preoperative comorbidities | Â | Â | Â |
Hypertension | 31 (55.3) | 27 (45.0) | 0.265 |
Coronary artery disease | 1 (1.78) | 3 (5.0) | 0.343 |
COPD | 0 | 2 (3.3) | 0.168 |
Parkinson’s disease | 0 | 1 (1.6) | 0.332 |
Fasting blood glucose | 6.9 [5.3, 8.5] | 7.1 [5.1, 9.1] | 0.608 |
Postprandial blood glucose | 10.0 [7.9, 12.1] | 9.4 [7.5, 11.3] | 0.128 |
Preoperative blood glucose control | Â | Â | Â |
Diet control | 7 (12.5) | 8 (13.3) | 0.894 |
Insulin | 12 (21.4) | 9 (15.0) | 0.369 |
Medicine | 35 (62.5) | 38 (63.3) | 0.926 |
Insulin + medicine | 2 (3.6) | 5 (8.3) | 0.282 |
Preoperative HBA1c (%) | 6.9 [6.5, 8.6] | 7.5 [6.6, 8.5] | 0.112 |